Literature DB >> 12838523

Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy.

Tina D Jeppesen1, Marianne Schwartz, David B Olsen, John Vissing.   

Abstract

The purpose of this study was to investigate the correlation between the level of mutated mitochondrial DNA in muscle and oxidative capacity in 24 patients with mitochondrial myopathy (MM). Maximal oxygen uptake (VO(2max)), workload (W(max)), and venous plasma lactate levels were measured during an incremental cycle test to exhaustion in 17 patients with point mutations of mtDNA and in seven with single, large-scale deletions of mtDNA (chronic progressive external ophthalmoplegia [CPEO]). Results were compared with those in 25 healthy matched subjects. The mutation load in MM patients was 67 +/- 5% (range, 29 - 99%). VO(2max) and W(max) correlated with percentage of heteroplasmy (r > 0.82; p < 0.005) and were lower in patients versus healthy subjects (p < 0.000005). Exercise-induced peak increases in heart rate, ventilation, and resting plasma lactate levels correlated with muscle mutation load (r > 0.71; p < 0.005). Exercise-induced increases in plasma lactate correlated with muscle mutation load in CPEO patients (r = 0.95; p < 0.005). Impaired oxidative capacity and ragged red muscle fibers were found in CPEO and 3243A-->G patients with mutation loads as low as 45 and 57%, respectively. The study indicates that oxidative capacity correlates directly with skeletal muscle mutation load in MM patients, and that the mutation threshold level for impaired oxidative metabolism in MM patients is lower than found in in vitro studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12838523     DOI: 10.1002/ana.10594

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Tissue specific distribution of the 3243A->G mtDNA mutation.

Authors:  A L Frederiksen; P H Andersen; K O Kyvik; T D Jeppesen; J Vissing; M Schwartz
Journal:  J Med Genet       Date:  2006-02-20       Impact factor: 6.318

2.  Detection of common disease-causing mutations in mitochondrial DNA (mitochondrial encephalomyopathy, lactic acidosis with stroke-like episodes MTTL1 3243 A>G and myoclonic epilepsy associated with ragged-red fibers MTTK 8344A>G) by real-time polymerase chain reaction.

Authors:  Hongxin Fan; Chris Civalier; Jessica K Booker; Margaret L Gulley; Thomas W Prior; Rosann A Farber
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

3.  Mitochondrial quality control: Cell-type-dependent responses to pathological mutant mitochondrial DNA.

Authors:  Adriana Malena; Boris Pantic; Doriana Borgia; Gianluca Sgarbi; Giancarlo Solaini; Ian J Holt; Antonella Spinazzola; Egle Perissinotto; Marco Sandri; Alessandra Baracca; Lodovica Vergani
Journal:  Autophagy       Date:  2016-09-14       Impact factor: 16.016

4.  Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome.

Authors:  Meghan S Soustek; Celine Baligand; Darin J Falk; Glenn A Walter; Alfred S Lewin; Barry J Byrne
Journal:  J Inherit Metab Dis       Date:  2015-04-10       Impact factor: 4.982

5.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

6.  The effects of nuclear reprogramming on mitochondrial DNA replication.

Authors:  Richard D W Kelly; Huseyin Sumer; Matthew McKenzie; Joao Facucho-Oliveira; Ian A Trounce; Paul J Verma; Justin C St John
Journal:  Stem Cell Rev Rep       Date:  2013-02       Impact factor: 5.739

7.  Physical fitness and mitochondrial respiratory capacity in horse skeletal muscle.

Authors:  Dominique-Marie Votion; Erich Gnaiger; Hélène Lemieux; Ange Mouithys-Mickalad; Didier Serteyn
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

8.  Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels.

Authors:  Masaki Kodaira; Hideyuki Hatakeyama; Shinsuke Yuasa; Tomohisa Seki; Toru Egashira; Shugo Tohyama; Yusuke Kuroda; Atsushi Tanaka; Shinichiro Okata; Hisayuki Hashimoto; Dai Kusumoto; Akira Kunitomi; Makoto Takei; Shin Kashimura; Tomoyuki Suzuki; Gakuto Yozu; Masaya Shimojima; Chikaaki Motoda; Nozomi Hayashiji; Yuki Saito; Yu-Ichi Goto; Keiichi Fukuda
Journal:  FEBS Open Bio       Date:  2015-03-20       Impact factor: 2.693

9.  Altered skeletal muscle (mitochondrial) properties in patients with mitochondrial DNA single deletion myopathy.

Authors:  Saskia Maria Gehrig; Violeta Mihaylova; Sebastian Frese; Sandro Manuel Mueller; Maria Ligon-Auer; Christina M Spengler; Jens A Petersen; Carsten Lundby; Hans H Jung
Journal:  Orphanet J Rare Dis       Date:  2016-07-29       Impact factor: 4.123

10.  m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction.

Authors:  Markus M Lindroos; Kari Majamaa; Andrea Tura; Andrea Mari; Kari K Kalliokoski; Markku T Taittonen; Patricia Iozzo; Pirjo Nuutila
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.